166 related articles for article (PubMed ID: 36423787)
21. Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target.
Jafarzadeh A; Paknahad MH; Nemati M; Jafarzadeh S; Mahjoubin-Tehran M; Rajabi A; Shojaie L; Mirzaei H
Biomed Pharmacother; 2022 Feb; 146():112600. PubMed ID: 34968919
[TBL] [Abstract][Full Text] [Related]
22. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
[TBL] [Abstract][Full Text] [Related]
23. CircRNA hsa_circ_0014130 function as a miR-132-3p sponge for playing oncogenic roles in bladder cancer via upregulating KCNJ12 expression.
Li G; Guo BY; Wang HD; Lin GT; Lan TJ; Ying H; Xu J
Cell Biol Toxicol; 2022 Dec; 38(6):1079-1096. PubMed ID: 34755307
[TBL] [Abstract][Full Text] [Related]
24. Molecular interactions of miR-338 during tumor progression and metastasis.
Moghbeli M
Cell Mol Biol Lett; 2021 Apr; 26(1):13. PubMed ID: 33827418
[TBL] [Abstract][Full Text] [Related]
25. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
[No Abstract] [Full Text] [Related]
26. The Roles of the Colon Cancer Associated Transcript 2 (CCAT2) Long Non-Coding RNA in Cancer: A Comprehensive Characterization of the Tumorigenic and Molecular Functions.
Pirlog R; Drula R; Nutu A; Calin GA; Berindan-Neagoe I
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830370
[TBL] [Abstract][Full Text] [Related]
27. Regulation of the Key Epithelial Cancer Suppressor miR-124 Function by Competing Endogenous RNAs.
Braga EA; Fridman MV; Burdennyy AM; Filippova EA; Loginov VI; Pronina IV; Dmitriev AA; Kushlinskii NE
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362406
[TBL] [Abstract][Full Text] [Related]
28. Non-coding RNAs in EMT regulation: Association with tumor progression and therapy response.
Sadrkhanloo M; Entezari M; Rashidi M; Hashemi M; Raesi R; Saghari S; Daneshi S; Salimimoghadam S; Hushmandi K; Mirzaei S; Taheriazam A
Eur J Pharmacol; 2022 Oct; 932():175212. PubMed ID: 36055365
[TBL] [Abstract][Full Text] [Related]
29. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
Ye F; Tian L; Zhou Q; Feng D
Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-301a Promotes Cell Proliferation and Resistance to Apoptosis through PTEN/PI3K/Akt Signaling Pathway in Human Ovarian Cancer.
Ni J; Chen Y; Fei B; Zhu Y; Du Y; Liu L; Guo L; Zhu W
Gynecol Obstet Invest; 2021; 86(1-2):108-116. PubMed ID: 33596588
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3.
Koo KH; Kwon H
Cell Death Dis; 2018 Jan; 9(2):77. PubMed ID: 29362401
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
Tu K; Liu Z; Yao B; Han S; Yang W
Int J Oncol; 2016 Mar; 48(3):965-74. PubMed ID: 26708293
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
35. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
[TBL] [Abstract][Full Text] [Related]
36. Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers.
Abadi AJ; Zarrabi A; Gholami MH; Mirzaei S; Hashemi F; Zabolian A; Entezari M; Hushmandi K; Ashrafizadeh M; Khan H; Kumar AP
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670518
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-494 promotes cervical cancer proliferation through the regulation of PTEN.
Yang YK; Xi WY; Xi RX; Li JY; Li Q; Gao YE
Oncol Rep; 2015 May; 33(5):2393-401. PubMed ID: 25738254
[TBL] [Abstract][Full Text] [Related]
38. miR-212-5p exerts tumor promoter function by regulating the Id3/PI3K/Akt axis in lung adenocarcinoma cells.
Chen FF; Sun N; Wang Y; Xi HY; Yang Y; Yu BZ; Li XJ
J Cell Physiol; 2020 Oct; 235(10):7273-7282. PubMed ID: 32039486
[TBL] [Abstract][Full Text] [Related]
39. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
[TBL] [Abstract][Full Text] [Related]
40. The emerging role of non-coding RNAs in the regulation of PI3K/AKT pathway in the carcinogenesis process.
Ghafouri-Fard S; Abak A; Tondro Anamag F; Shoorei H; Majidpoor J; Taheri M
Biomed Pharmacother; 2021 May; 137():111279. PubMed ID: 33493969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]